Urinary Catecholamines Predict Relapse During Complete Remission in High-Risk Neuroblastoma
JCO Precis Oncol. 2025 Jan;9:e2400491. doi: 10.1200/PO-24-00491. Epub 2025 Feb 21. ABSTRACT PURPOSE: Urinary catecholamine metabolites are well-known biomarkers for the diagnosis (Dx) of neuroblastoma, …